This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs

Event Date: 05/02/2019
Location: Washington, DC
Subject: Food and Drug Law Institute Annual Conference: FDA Priorities
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Government, media, industry, and other registered guests

Event Date: 05/02/2019
Location: Washington, DC
Subject: Reagan-Udall Foundation 2019 Annual Public Meeting: Agency Priorities
FDA Participant/Group: AMY ABERNETHY; JEFFREY SHUREN; SUSAN MAYNE; JANET WOODCOCK; PETER MARKS;
Non FDA Participant/Group: Government, industry, media, and other registered guests

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

Event Date: 04/29/2019
Location: Silver Spring, MD
Subject: Public Meeting: Patient Perspectives on the Impact of Rare Diseases: Bridging the Commonalities
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Patients, caregivers, health professionals, and industry related to rare diseases

Event Date: 04/30/2019
Location: Silver Spring, MD
Subject: MITRE Briefing on Federally Funded Research and Development Center (FFRDC): Health Pilot
FDA Participant/Group: PAUL HOWARD; JOSEPH FRANKLIN; KELLY NORSWORTHY; SEAN KHOZIN; JESSICA BERRELLEZ;
Non FDA Participant/Group: Monica Bertagnolli (American Society of Clinical Oncology); Keri Reardon, Steven Piantadosi (The Alliance for Clinical Trials in Oncology); Brian Anderson, Erin Williams, Jay Schnitzer (The MITRE Corporation); Lawrence Schwartz (New York Presbyterian Hospital);

Event Date: 05/02/2019
Location: Washington, DC
Subject: Medical Device Manufacturers Association 2019 Annual Meeting: Driving the Future of Healthcare
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Government, industry, academia, and the health care services field

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Lowell J. Schiller, Principal Associate Commissioner for Polcy

Event Date: 05/02/2019
Location: Silver Spring, MD
Subject: Dietary Supplements Quality Collaborative Meeting
FDA Participant/Group: CAITLIN BOON; ALEXANDRA HEARD; CARA WELCH; STEVEN TAVE; TRACEY SANDERS;
Non FDA Participant/Group: Elise Ackley (The Pew Charitable Trusts); Jay Sirois (Healthcare Products Association); Steve Mister (Council for Responsible Nutrition); Carrie Harney (Dietary Supplements Quality Collaborative); Elizabeth Miller (The United States Pharmacopeial Convention);

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 04/30/2019
Location: Washington, DC
Subject: Food Marketing Institute: FDA Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the Food Marketing Institute, Government Relations and Public Affairs Committee

Event Date: 05/02/2019
Location: Washington, DC
Subject: American Frozen Food Institute Board Meeting
FDA Participant/Group: SUSAN KELLY;
Non FDA Participant/Group: N/A

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Keagan Lenihan, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 05/02/2019
Location: Washington, DC
Subject: Food and Drug Law Institute Annual Conference: Goals and Priorities for CDER
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: N/A

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 04/28/2019
Location: Washington, DC
Subject: American Society of Gene and Cell Therapy 22nd Annual Meeting: FDA's Approach to Facilitating the Development of Gene Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 05/01/2019
Location: Washington, DC
Subject: American Society of Gene and Cell Therapy 22nd Annual Meeting: FDA's Programs to Promote Patient Access to Investigational Therapies
FDA Participant/Group: WILSON BRYAN;
Non FDA Participant/Group: N/A

Event Date: 05/02/2019
Location: Washington, DC
Subject: Food and Drug Law Institute Annual Conference: Exploring Advanced Topics in Food and Drug Law: Center for Biologics Evaluation and Research Update
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 04/30/2019
Location: Washington, DC
Subject: 2019 KidneyX Summit: FDA Role
FDA Participant/Group: MURRAY SHELDON;
Non FDA Participant/Group: N/A

Event Date: 05/02/2019
Location: Washington, DC
Subject: Food and Drug Law Institute Annual Conference: Center Director Session
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 05/03/2019
Location: Silver Spring, MD
Subject: Digital Health and Precertification Pilot
FDA Participant/Group: WILLIAM MAISEL; BRADLEY CUNNINGHAM; JESSICA PAULSEN; BAKUL PATEL;
Non FDA Participant/Group: Eric Friedman, Gloria Lee (Fitbit, Inc.);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date: 04/29/2019
Location: Little Rock, AR
Subject: The Delta Directions Consortium
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, and other invited guests

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event